The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Table 3 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Pathology Outlines - Kappa & lambda light chains
Cureus | Myeloma Cast Nephropathy and COVID-19: A Case Report of Multiple Myeloma Presenting as Acute Kidney Injury in the Setting of COVID-19
Crystalline light chain proximal tubulopathy and podocytopathy: a case report. – Dr. Leonardo Riella
Manni Mohyuddin on Twitter: "Well- Normally kappa FLC are produced more often than lambda.. BUT lambda more frequently forms dimers, which doubles their molecular weight and slows their renal clearance..." / Twitter
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Kidney Biopsy of the Month: Light Chain Cast Nephropathy - Renal Fellow Network
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - Kidney International
JCM | Free Full-Text | The Clone Wars: Diagnosing and Treating Dysproteinemic Kidney Disease in the Modern Era | HTML
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Monoclonal gammopathy of renal significance: Early diagnosis is key | Nefrología
4/27/2018 1 MULTIPLE MYELOMA: WHAT'S NEW?
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology